![]() | |
Long title | An Act to amend the Federal Food, Drug, and Cosmetic Act to revitalize the Food and Drug Administration, and for other purposes. |
---|---|
Nicknames | Food and Drug Administration Revitalization Act of 1990 |
Enacted by | the 101st United States Congress |
Effective | November 28, 1990 |
Citations | |
Public law | 101-635 |
Statutes at Large | 104 Stat. 4583 |
Codification | |
Acts amended | Federal Food, Drug, and Cosmetic Act |
Titles amended | 21 U.S.C.: Food and Drugs |
U.S.C. sections amended |
|
Legislative history | |
|
The Food and Drug Administration Revitalization Act was introduced by the 101st Congress of the United States. Senator Orrin G. Hatch was the chairperson sponsor of the federal revitalization amendment for the Food and Drug Administration. [1]
The FDA revitalization was orchestrated by Commissioner of Food and Drugs Dr. David Kessler in pursuant of the congressional authorization permissible by 101st Senate bill 845; [2] [3] [4]
The Title 21 amendment was signed into law on November 28, 1990, by President George H. W. Bush.
The Food and Drug Administration Revitalization Act of 1990 was penned with four legislative titles establishing a medium for the rejuvenation of the public health agency.
Title I: Administrative and Laboratory Facility Consolidation - 21 U.S.C. § 379b
Title II: Recovery and Retention of Fees for FOIA Requests - 21 U.S.C. § 379c
Title III: Scientific Review Groups - 21 U.S.C. § 394
Title IV: Automation of FDA - 21 U.S.C. § 379d